Brief: Biomed Lublin FY 2021 Net Profit Down At 4.2 Mln Zlotys

Synthaverse SA

14/04/2022 07:44

April 14 (Reuters) - Biomed Lublin Wytwornia Surowic i
Szczepionek SA  BML.WA :
    * FY 2021 NET PROFIT 4.2 MILLION ZLOTYS VERSUS 4.4 MILLION
ZLOTYS
YEAR AGO
    * FY 2021 SALES REVENUE 41.2 MILLION ZLOTYS VERSUS 40.2
MILLION
ZLOTYS YEAR AGO
    * FY 2021 OPERATING PROFIT 7.2 MILLION ZLOTYS VERSUS 5.9
MILLION
ZLOTYS YEAR AGO
    * EBITDA 13.5 MILLION ZLOTYS VERSUS 11.8 MILLION ZLOTYS YEAR
AGO

Source text for Eikon:  urn:newsml:reuters.com:*:nEM31Pg7La
Further company coverage:  BML.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))